test

Ryan Cappelli

@Prosight Management, Lp

Latest period2024 - Q3ReportedManaged Assets$406.357MTotal holdings45
Assets growth rate21.46%Assets growth rate (2-Q avg)7.27%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Prosight Management, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 45 positions.

Assets under management

The assets under management (AUM) of Prosight Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 406.357M in assets, with a quarterly growth rate of 21.46% and a 2-quarter average growth rate of 7.27%. The portfolio is managed by Ryan Cappelli, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SGHTSight Sciences Inc
Recent Activity
New Position
0.83%
$3.347M
531,222 shares@ $6.31 avg price
VKTXViking Therapeutics Inc
Recent Activity
Decreased -58.26%
0.75%
$3.039M
48,000 shares@ $63.31 avg price
RCKTRocket Pharmaceuticals Inc
Recent Activity
New Position
0.73%
$2.944M
159,369 shares@ $18.47 avg price
CRBPCorbus Pharmaceuticals Hldgs
Recent Activity
New Position
0.66%
$2.682M
130,000 shares@ $20.63 avg price
MURAMural Oncology Pub Ltd Co
Recent Activity
Increased 20.02%
0.44%
$1.786M
570,620 shares@ $3.14 avg price
MRVIMaravai Lifesciences Hldgs I
Recent Activity
New Position
0.43%
$1.73M
208,200 shares@ $8.31 avg price
VINCVincerx Pharma Inc
Recent Activity
Decreased -11.32%
0.39%
$1.58M
2.207M shares@ $0.72 avg price
ALRNAileron Therapeutics Inc
Recent Activity
Increased 40.44%
0.33%
$1.317M
372,157 shares@ $3.55 avg price
2210⤦Corvel Corp
Recent Activity
New Position
0.23%
$915,292↓ Put
2,800 shares@ $326.89 avg price
SEMSelect Med Hldgs Corp
Recent Activity
New Position
0.23%
$908,887
26,065 shares@ $34.88 avg price